BRIEF-Outlook Therapeutics Announces Commercial Launch Of Lytenava In Germany And UK For Treatment Of Wet AMD

Reuters
02 Jun
BRIEF-Outlook <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Commercial Launch Of Lytenava In Germany And UK For Treatment Of Wet AMD

June 2 (Reuters) - Outlook Therapeutics Inc OTLK.O:

  • OUTLOOK THERAPEUTICS® ANNOUNCES COMMERCIAL LAUNCH OF LYTENAVA™ (BEVACIZUMAB GAMMA) IN GERMANY AND THE UK FOR THE TREATMENT OF WET AMD

  • OUTLOOK THERAPEUTICS INC - LYTENAVA APPROVED FOR WET AMD IN EU AND UK

Source text: ID:nGNX54rbXl

Further company coverage: OTLK.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10